Close this search box.

A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HCC

SOCRATES HCC will investigate whether a radiotherapy technique (called SABR) can treat early stage liver cancer more effectively than current treatments which use heating probes directly inserted into the tumour or chemotherapy or radioactive particles injected into the blood supply of the tumour.

Primary Sponsor

Trans Tasman Radiation Oncology Group (TROG)

Collaborating Groups

Australasian Gastro-Intestinal Trials Group (AGITG), Abdominal Radiology Group of Australia and New Zealand (ARGANZ) & Gastrointestinal Society of Australia (GESA)

Participating Centres

Accrual Target


Current Accrual

Trial Chairperson

Prof Alan Wigg, Flinders Medical Centre, SA, Australia
A/Prof David Pryor, Princess Alexandra Hospital, QLD, Australia

Trial Contact

Clinical Trial Registration

Related Post

18 October, 2022

NINJA Radiation Therapy Trial participant tells his journey to treatment

The journey to becoming the 200th participant for the

6 September, 2022

The gift that kept on giving

The NewyWay Coffee Collaboration Newcastle marketing agency, The Marketing